• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Three cases of palmoplantar pustulosis successfully treated with apremilast.

作者信息

Eto Ayaka, Nakao Masayoshi, Furue Masutaka

机构信息

Department of Dermatology, Steel Memorial Yawata Hospital, Fukuoka, Japan.

Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

J Dermatol. 2019 Jan;46(1):e29-e30. doi: 10.1111/1346-8138.14516. Epub 2018 Jun 15.

DOI:10.1111/1346-8138.14516
PMID:29905386
Abstract
摘要

相似文献

1
Three cases of palmoplantar pustulosis successfully treated with apremilast.三例掌跖脓疱病经阿普斯特治疗成功
J Dermatol. 2019 Jan;46(1):e29-e30. doi: 10.1111/1346-8138.14516. Epub 2018 Jun 15.
2
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.阿普米司特，一种口服磷酸二酯酶-4 抑制剂，治疗掌跖银屑病：来自 PSOR-005 Ⅱ期和 Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis（ESTEEM）Ⅲ期临床试验的汇总分析结果，该试验入组了中重度银屑病患者。
J Am Acad Dermatol. 2016 Jul;75(1):99-105. doi: 10.1016/j.jaad.2016.02.1164. Epub 2016 Mar 24.
3
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.阿普米司特治疗中重度掌跖银屑病：一项双盲、安慰剂对照、随机研究的结果。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):403-410. doi: 10.1111/jdv.14647. Epub 2017 Nov 15.
4
Apremilast: A Review in Psoriasis and Psoriatic Arthritis.阿普米司特：用于治疗银屑病和银屑病关节炎的药物评价。
Drugs. 2015 Aug;75(12):1393-403. doi: 10.1007/s40265-015-0439-1.
5
Drug survival of apremilast in a real-world setting.阿普米司特在真实环境中的药物生存情况。
J Dermatol. 2019 Jul;46(7):615-617. doi: 10.1111/1346-8138.14943. Epub 2019 Jun 10.
6
Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial.阿普司特，一种口服磷酸二酯酶4抑制剂，用于治疗日本中重度斑块状银屑病患者：2b期随机对照试验的疗效、安全性和耐受性结果
J Dermatol. 2017 Aug;44(8):873-884. doi: 10.1111/1346-8138.13829. Epub 2017 Apr 9.
7
Apremilast for the management of moderate to severe plaque psoriasis.阿普米拉斯用于治疗中度至重度斑块状银屑病。
Expert Rev Clin Pharmacol. 2017 Apr;10(4):349-360. doi: 10.1080/17512433.2017.1293519. Epub 2017 Feb 17.
8
Real-world, single-centre experience of apremilast for the treatment of moderate to severe psoriasis.阿普司特治疗中度至重度银屑病的真实世界单中心经验。
Clin Exp Dermatol. 2017 Aug;42(6):675-676. doi: 10.1111/ced.13150. Epub 2017 Jun 16.
9
Real-world use of apremilast for patients with psoriasis in Japan.日本银屑病患者阿普米司特的真实世界应用。
J Dermatol. 2018 Nov;45(11):1345-1348. doi: 10.1111/1346-8138.14617. Epub 2018 Aug 31.
10
Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast.用阿普斯特成功治疗的寻常型银屑病合并系统性红斑狼疮
J Dermatol. 2019 Jun;46(6):e219-e221. doi: 10.1111/1346-8138.14728. Epub 2018 Dec 10.

引用本文的文献

1
Recent advances in palmoplantar pustulosis.掌跖脓疱病的最新进展
Fac Rev. 2021 Jul 27;10:62. doi: 10.12703/r/10-62. eCollection 2021.
2
Apremilast monotherapy for palmoplantar pustulosis: Report of three cases.阿普米拉斯单药治疗掌跖脓疱病：三例报告。
SAGE Open Med Case Rep. 2021 Aug 11;9:2050313X211034926. doi: 10.1177/2050313X211034926. eCollection 2021.
3
Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study.阿普司特治疗掌跖脓疱病的即刻反应：一项回顾性试点研究。
Int J Dermatol. 2021 May;60(5):570-578. doi: 10.1111/ijd.15382. Epub 2021 Jan 17.
4
[Apremilast in the treatment of palmoplantar pustulosis : A case series].阿普司特治疗掌跖脓疱病：病例系列
Hautarzt. 2021 Mar;72(3):252-256. doi: 10.1007/s00105-020-04676-2.
5
Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.掌跖脓疱病：发病机制和新兴治疗方法的最新进展。
Am J Clin Dermatol. 2020 Jun;21(3):355-370. doi: 10.1007/s40257-020-00503-5.
6
Off-label studies on apremilast in dermatology: a review.阿普斯特在皮肤科的超适应证研究：综述。
J Dermatolog Treat. 2020 Mar;31(2):131-140. doi: 10.1080/09546634.2019.1589641. Epub 2019 Apr 2.
7
Apremilast in Psoriasis and Beyond: Big Hopes on a Small Molecule.阿普司特治疗银屑病及其他疾病：对一种小分子药物寄予厚望
Indian Dermatol Online J. 2019 Jan-Feb;10(1):1-12. doi: 10.4103/idoj.IDOJ_437_18.